WuXi Biologics announces new discovery, development and manufacturing site in China

By Flora Southey contact

- Last updated on GMT

WuXi Biologics has broken ground on its Biologics Innovation Center in Shanghai, China
WuXi Biologics has broken ground on its Biologics Innovation Center in Shanghai, China

Related tags: Wuxi biologics, CDMO, China

The CDMO has broken ground on its 1.6 million-square-foot Biologics Innovation Center in Shanghai.

Contract development and manufacturing organisation (CDMO) WuXi Biologics has announced plans to build its Biologics Innovation Center in the Fengxian district of Shanghai.

The 1.6 million-square-foot centre will house discovery and development laboratories, alongside good manufacturing practice (GMP) capabilities for commercial production.

WuXi Biologics' Innovation Center, Shanghai, China

Laboratory facilities are due to open in 2019, with GMP manufacturing expected to launch in 2021. The site will accommodate more than 3,000 scientists recruited predominantly from China.

According to CEO Chris Chen, the build responds to growing demand for the manufacture of large molecule drugs: “We have a portfolio of 187 biologics [that require] manufacturing and the number of projects is still growing,” ​we were told. The Innovation Center brings “everything in one place,” ​he continued.

The firm did not disclose the cost of the build, nor provide specifics on the site’s “significant”​ bioreactor capacity.

The announcement adds to the Chinese CDMO’s growing site network, which also includes plans for international expansion in Ireland​, Singapore​, and the US​.

Related news

Show more

Related products

show more

Eastern & Western Manufacturing Solutions

Eastern & Western Manufacturing Solutions

Piramal Pharma Solutions | 07-Dec-2021 | Technical / White Paper

The best manufacturing site for a product can change throughout the life cycle. When bringing new drugs to market, biopharma companies may benefit from...

Flexibility and capability in pre-filled syringes

Flexibility and capability in pre-filled syringes

Curia | 15-Nov-2021 | Technical / White Paper

Pre-filled syringes have risen in popularity in recent years but the pandemic’s impact on drug development, manufacturing and patient care has created...

What to consider when working with CRFs

What to consider when working with CRFs

Formedix | 01-Nov-2021 | Technical / White Paper

For a study to be successful, data collected must be correct and complete. To be correct and complete, forms must be well planned with meticulous attention...

Related suppliers

Follow us

Products

View more

Webinars